HOME >> MEDICINE >> NEWS
Artificial liver moves toward commercialization

Emergency device could save lives

SAN FRANCISCO -- In cases of severe liver failure, often the only effective alternative to keep a patient alive is a liver transplant. Due to a severe shortage of donor organs, many patients die waiting for suitable organs. An artificial liver that provides temporary support of a person's liver function can serve as a bridge to transplant or as a short-term treatment. Prototype devices, which filter blood toxins that build up as a result of liver damage, have been used in limited clinical trials to support patients. Advances in the development of this device, which could save many lives in the future, will be highlighted at the 219th national meeting of the American Chemical Society, the world's largest scientific society.

  • Upgraded device awaits human trials: The University of Minnesota bioartificial liver is among the earliest prototype devices still under development. To make it function longer than other models, researchers are using freshly isolated pig liver cells -- believed to work better than frozen liver cells -- as the substitute chemical-processing unit for the patient's liver. The first human clinical trials of this prototype device are scheduled to begin soon, pending U. S. Food and Drug Administration approval, among several patients with severe liver failure. (D. N. Adams, University of Minnesota, Minneapolis, Minn.; BIOT 81; Monday, March 27, 4:25 p.m.; Moscone Convention Center, Room 300, Esplanade Level. See page 68 in the final program.)

  • Improving device performance: Artificial livers currently being tested employ straight-line hollow fiber bioreactors to house the chemical-processing cells that substitute for the human liver. Such devices are subject to clogging and transport difficulties, resulting in poor transport of nu
    '"/>


Contact: charmayne Marsh
y_marsh@acs.org
202-872-4445
American Chemical Society
26-Mar-2000


Page: 1 2

Related medicine news :

1. Artificial liver trials show progress, as transplant candidates wait
2. Artificial organs
3. New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease
4. Trial Begins For First Artificial Liver Device Using Human Cells
5. Research offers hope of new treatments for liver damage
6. Success of liver transplantation may be most influenced by three risk factors
7. Alcohol relapse adversely affects 10-year liver transplant survival
8. Donor age has no affect on long-term liver transplant survival
9. NHS stop-smoking services are insufficient to deliver national smoking targets
10. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
11. Component of green tea protects injured livers in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
Breaking Medicine Technology:
Cached News: